Hadassah

Complex, Less Debilitating Treatment for Neuroendocrine Cancer Now Available in Israel at Hadassah

Wednesday, Feb 15 2012

A treatment for neuroendocrine cancer that was previously only available abroad is now being provided at the Hadassah University Medical Center. Patients are injected with radioactive material that attaches to the malignant cell, absorbing and destroying it with minimal damage to other tissue. The new treatment is the outgrowth of three years of collaboration between Hadassah and Israel's Soreq Nuclear Research Center, an applied research and development institute affiliated with the Israel Atomic Energy Commission. The radioactive material is assembled at the Soreq Center and sent to Hadassah once a week at a set time.

Based on the fact that these endocrine tumors have an increased ability to absorb a hormone called somatostatin, the therapeutic procedure involves attaching a similar molecule to the hormone which is, in turn, attached to a radioactive atom. The atom binds to receptors on the outer membrane of the tumor and is absorbed into the malignant cell, emitting ionizing radiation which destroys it.

According to Dr. Asher Salmon, Senior Oncologist at Hadassah's Sharett Institute of Oncology, the treatment successfully prolongs life expectancy for 80 percent of patients and retards the progress of the disease for 50 percent. "This treatment, considered one of the best and most innovative available, differs from chemotherapy, providing prolonged relief for the patients with only a few side effects," he says. Following just one day in the hospital, patients are sent home; within several days, they can resume their normal lives.

Hadassah's departments of endocrinology, oncology, nuclear medicine, and radiology collaborate in providing this treatment to Hadassah's patients.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, Dec 10 2018

A Nurses Council Celebration in Israel: The Milestone Mission

We were honored to meet so many dynamic Hadassah nurses, some longtime and some new members--all of us excited to be together to celebrate the 100th anniversaries of the Hadassah Medical Organization, the Henrietta Szold Hadasssah-Hebrew University Nursing School and HMO's Department of Ophthalmology. And Israel's 70th

READ MORE ›
alt_text

Wednesday, Dec 5 2018

Prof. Chowers’ Long and Meaningful Hadassah Connections

Sophie Szold, mother of Hadassah founder Henrietta, wept when she saw children with flies in their eyes on their maiden trip to pre-state Israel in 1909. Those children had trachoma, endemic in the Middle East in those days.

READ MORE ›
alt_text

Wednesday, Dec 5 2018

Ending the Violence Against Women: Hadassah Staff Joins Nationwide Protests

On December 4, employees from both Hadassah Hospital Ein Kerem and Hadassah Hospital Mount Scopus rallied to end violence against women. “Together we will banish the darkness and return the light to all women,” read banners held by the participants.

READ MORE ›
alt_text

Tuesday, Dec 4 2018

No Ovaries? Mystery Solved By Hadassah Endocrinologist

A few years ago, a mother brought her teenage daughter to see Prof. David Zangen, Director of Pediatric Endocrinology at the Hadassah Medical Organization.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More